CyberKnife radical cure for early lung adenocarcinoma: a case was confirmed by postoperative pathology.
OpenAlex 토픽 ·
Lung Cancer Diagnosis and Treatment
Hepatocellular Carcinoma Treatment and Prognosis
Radiomics and Machine Learning in Medical Imaging
The utilization of pathological assessment to evaluate tumor response in patients with early-stage non-small cell lung cancer (NSCLC) has not been documented in the extant literature.
APA
T Wang, Jingjing Fan, et al. (2026). CyberKnife radical cure for early lung adenocarcinoma: a case was confirmed by postoperative pathology.. Lung cancer management, 15(1), 2625649. https://doi.org/10.1080/17581966.2026.2625649
MLA
T Wang, et al.. "CyberKnife radical cure for early lung adenocarcinoma: a case was confirmed by postoperative pathology.." Lung cancer management, vol. 15, no. 1, 2026, pp. 2625649.
PMID
41701181
Abstract
The utilization of pathological assessment to evaluate tumor response in patients with early-stage non-small cell lung cancer (NSCLC) has not been documented in the extant literature. A 64-year-old male patient with lung adenocarcinoma was treated with CyberKnife. A subsequent review of the images suggested that the mass in the area of radiotherapy had increased in size compared to the previous one, suggesting tumor recurrence. Consequently, surgery was performed to remove the enlarged mass. Postoperative histopathology showed no tumor tissue. This case underscores the potential efficacy of CyberKnife in the treatment of early-stage non-small cell lung cancer (NSCLC) tumors and confirms its effectiveness as a radical treatment modality, as validated by the gold standard of postoperative pathology.
같은 제1저자의 인용 많은 논문 (5)
- Pancancer Fine-Mapping of Mutational Intolerance Identifies CHEK1 as an Immunosuppressive Driver in Lung Adenocarcinoma.
- AS1411-aptamer-functionalized DNA tetrahedron for targeted delivery of vorinostat to suppress gastric cancer progression via ferroptosis induction and epithelial-mesenchymal transition inhibition.
- Clinical Pharmacology Characterization of Bispecific T-Cell Engagers: A Summary Based on FDA Approvals.
- Apalutamide-induced severe cutaneous adverse reactions in prostate cancer: a comprehensive review of reported cases and clinical strategies.
- Dynamic Contrast-Enhanced MRI Kinetic Curve-Driven Parametric Radiomics for Predicting Breast Cancer Molecular Subtypes: A Multicenter and Interpretable Study.